sacituzumab govitecan
gilead sciences
['tropics-02', 'breast', 'sacituzumab']
asco 2022 news: tropics-02 data show a significant pfs benefit with sacituzumab govitecan vs chemotherapy in heavily pretreated patients with hr+/her2 advanced breast cancer.
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.